| RS192651565 |
ST3GAL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1926524710 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS192653658 |
PEX12
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 3A (Zellweger), Peroxisome biogenesis disorder 3A (Zellweger) |
| RS1926541478 |
PCDH19
|
Health Risk |
Pathogenic |
Complex febrile seizure, Complex febrile seizure |
| RS192654796 |
SCD5
|
Health Risk |
Pathogenic |
Hearing loss, autosomal dominant 79 |
| RS192655097 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS192656109 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, FG syndrome |
| RS1926563302 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1926563553 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS192656357 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1926563964 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, Thyroid cancer |
| RS192656420 |
CREB3L1
|
Health Risk |
Conflicting classifications of pathogenicity |
CREB3L1-related disorder, Inborn genetic diseases |
| RS1926565039 |
NR0B1
|
Health Risk |
Likely pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS1926565370 |
NR0B1
|
Health Risk |
Pathogenic |
— |
| RS1926565907 |
NR0B1
|
Health Risk |
Pathogenic |
46, XY sex reversal 2 |
| RS1926575027 |
NR0B1
|
Health Risk |
Pathogenic |
NR0B1-related disorder, NR0B1-related disorder |
| RS1926588125 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1926588297 |
BTK
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia |
| RS1926599738 |
NR0B1
|
Health Risk |
Pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS1926602170 |
NR0B1
|
Health Risk |
Pathogenic |
46, XY sex reversal 2 |
| RS1926614700 |
BTK
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia |
| RS1926616715 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1926617807 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1926620965 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS1926621737 |
ATP6AP2
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type IIr |
| RS192665139 |
ACSL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Non-syndromic X-linked intellectual disability, Non-syndromic X-linked intellectual disability |
| RS1926691614 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS192669216 |
BICD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures, Inborn genetic diseases |
| RS192669225 |
AMPD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Global developmental delay, Brain malformation |
| RS1926696248 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1926705172 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS1926706805 |
PEX26
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7A (Zellweger) |
| RS1926708861 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1926710166 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia |
| RS1926711302 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS192673935 |
SHOC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome-like disorder with loose anagen hair 1, Noonan syndrome-like disorder with loose anagen hair 1 |
| RS192675802 |
DACH1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1926794975 |
PEX26
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS1926795050 |
ATP6AP2
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Hedera type, Syndromic X-linked intellectual disability Hedera type |
| RS192679574 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS192681330 |
LBR
|
Health Risk |
Pathogenic |
— |
| RS1926837956 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1926838663 |
CDKL5
|
Health Risk |
Pathogenic |
Angelman syndrome-like, Developmental and epileptic encephalopathy |
| RS192686066 |
CTNNA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Patterned macular dystrophy 2 |
| RS1926865530 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1926867009 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1926867732 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1926868266 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1926870020 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1926871732 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1926871899 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1926873715 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1926874291 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1926875686 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS192688285 |
LPIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Myoglobinuria, acute recurrent |
| RS192691397 |
FAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
FAT1-related disorder, FAT1-related disorder |
| RS1926975943 |
BTK
|
Health Risk |
Pathogenic |
— |
| RS1926977049 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1927001903 |
CDKL5
|
Health Risk |
Pathogenic |
CDKL5 disorder, CDKL5 disorder |
| RS1927008194 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1927009899 |
CHM
|
Health Risk |
Pathogenic |
— |
| RS1927017073 |
CHM
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1927036027 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, Thyroid cancer |
| RS1927036604 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia, X-linked agammaglobulinemia |
| RS192704075 |
SPART
|
Health Risk |
Conflicting classifications of pathogenicity |
Troyer syndrome, Troyer syndrome |
| RS1927078072 |
RAC2
|
Health Risk |
Pathogenic |
Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia, Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia |
| RS1927110683 |
RAC2
|
Health Risk |
Likely pathogenic |
Neutrophil immunodeficiency syndrome, Neutrophil immunodeficiency syndrome |
| RS1927126429 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS192712847 |
VSX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microphthalmia, isolated |
| RS1927131178 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1927139054 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1927142990 |
CDKL5
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 2 |
| RS1927146242 |
CDKL5
|
Health Risk |
Likely pathogenic |
CDKL5-related disorder, CDKL5-related disorder |
| RS1927146374 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1927166327 |
BTK
|
Health Risk |
Likely pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS1927168815 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia |
| RS1927172387 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia with growth hormone deficiency |
| RS192717273 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS192721019 |
STAMBP
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly-capillary malformation syndrome, Microcephaly-capillary malformation syndrome |
| RS192722540 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1S, Hypertrophic cardiomyopathy |
| RS192732174 |
GLB1
|
Health Risk |
Pathogenic/Likely pathogenic |
GM1 gangliosidosis type 2, Infantile GM1 gangliosidosis |
| RS1927322453 |
F9
|
Health Risk |
Pathogenic |
Hemophilia B leyden, Hemophilia B leyden |
| RS1927322926 |
F9
|
Health Risk |
Pathogenic/Likely pathogenic |
Hemophilia B leyden, Thrombophilia |
| RS1927328297 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1927329129 |
F9
|
Health Risk |
Likely pathogenic |
Thrombophilia, X-linked |
| RS192734396 |
SMC1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1927349741 |
SOX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Panhypopituitarism, X-linked |
| RS1927377513 |
STS
|
Health Risk |
Likely pathogenic |
X-linked ichthyosis with steryl-sulfatase deficiency, X-linked ichthyosis with steryl-sulfatase deficiency |
| RS1927393826 |
RAC2
|
Health Risk |
Likely pathogenic |
Immunodeficiency 73b with defective neutrophil chemotaxis and lymphopenia, Neutrophil immunodeficiency syndrome |
| RS192739957 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS192740549 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS192749274 |
IL10RA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inflammatory bowel disease 28, Inborn genetic diseases |
| RS1927493197 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS1927497998 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1927498635 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1927499978 |
F9
|
Health Risk |
Likely pathogenic |
— |
| RS1927507602 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1927508585 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1927509977 |
TMPRSS6
|
Health Risk |
Pathogenic |
Microcytic anemia, Microcytic anemia |
| RS1927567325 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |